Risk factors for post-hepatectomy liver failure in 80 patients

Table 1 Comparisons of general data between the two groups

	PHLF group (n = 19)	Non-PHLF group (n = 61)
Gender
Male	16 (84.21%)	22 (36.07%)
Female	3 (15.79%)	39 (63.93%)
Age (yr)	60 (50,68)	57 (51,62)
History of hepatitis	9 (47.37%)	7 (11.48%)
History of diabetes	4 (21.05%)	5 (8.2%)
Liver cirrhosis	9 (47.37%)	4 (6.56%)
Operating time (h)	6.13-2.3	5.3-1.78
Bleeding (mL)	400 (200, 500)	300 (200, 500)
Hepatic hilum occlusion	9 (47.37%)	27 (44.26%)
ALT	28 (14.5, 40.1)	17.2 (10.4, 26.4)
AST	37.6 (25.2, 43.1)	20.1 (15.4, 25.7)
TBIL	21.4 (17.5, 36.2)	13.9 (10.6, 18.2)
DBIL	7 (5.8, 10.3)	5.1 (3.34, 7.7)
Creatinine	53 (41.4, 64.9)	50.3 (43.8, 61.1)
eGFR	120.66 (99.73, 129.65)	113.59 (105.84, 120.44)
ALB	35.67-6	39.45-3.66
WBC	4.8 (3.19, 6.73)	6.14 (4.98, 7.35)
LY	1.29 (0.86, 1.6)	1.39 (1.12, 1.85)
PLT	119.11-43.9	214.11-67.27
PT	11.5 (10.8, 13.3)	11.1 (10.6, 11.9)
INR	1.07 (1.03, 1.21)	1.02 (0.98, 1.1)
MELD	10 (8, 11)	7 (7, 8)
ALBI	-2.1-0.62	-2.59-0.33
APRI	0.78 (0.64, 1.04)	0.24 (0.17, 0.4)
Total liver volume	1385.26 (1239.85, 1487.93)	1294.16 (1174.19, 1385.63)
Remnant liver volume	854.12 (767.42, 1085.13)	984.13 (874.59, 1095.52)
Spleen volume	206.19 (176.83, 439.16)	162.79 (153.86, 175.23)
SV/LV	0.15 (0.13, 0.34)	0.12 (0.11, 0.14)
%RLV	0.65-0.14	0.76-0.08
BMI	23.11-2.4	23.6-2.48
Body surface area	1.73-0.14	1.68-0.12
SLV	1223.28-97.52	1188.79-86.27
SRLVR	0.7 (0.58, 0.85)	0.83 (0.75, 0.94)

PHLF: Post-hepatectomy liver failure; APRI: Aspartate aminotransferase-to-platelet ratio index; SV/LV: Spleen volume/Liver volume ratio; RLV: Remnant liver volume; BMI: Body Mass Index; SLV: Standard liver volume; AST: Aspartate aminotransferase.